Course summary
Introduction As biomedical research moves beyond animal testing, organ-on-a-chip systems are at the forefront of emerging medical technologies — enabling realistic, human-centred models that advance understanding of disease mechanisms and therapeutic responses. This unique, industry-led MSc course, delivered within the renowned Centre for Predictive In Vitro Models, provides advanced training in next-generation organ-on-a-chip, tissue engineering and in vitro technologies — preparing you to shape the future of healthcare. Programme Highlights
- Study a future-facing course at the forefront of technologies that will revolutionise personalised medicine and reduce animal testing.
- Work within one of Europe's largest and most advanced organ-on-a-chip facilities.
- Gain insights from our network of 150+ industry partners across pharma, biotech, and regulatory agencies.
- Queen Mary is ranked within the top 70 universities in the world for Medicine and Life Sciences (QS World University Rankings by Subject, 2025).
Entry requirements
Good 2:2 (55% or above) in a related subject.
Fees and funding
Tuition fees
No fee information has been provided for this course
Tuition fee status depends on a number of criteria and varies according to where in the UK you will study. For further guidance on the criteria for home or overseas tuition fees, please refer to the UKCISA website .
Additional fee information
No additional fees or cost information has been supplied for this course, please contact the provider directly.
Provider information
Queen Mary University of London
Admissions and Recruitment Office
Mile End Road
Tower Hamlets
London
E1 4NS